Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

被引:125
作者
Bodles, AM [1 ]
Guthrie, DJS [1 ]
Greer, B [1 ]
Irvine, GB [1 ]
机构
[1] Queens Univ Belfast, Sch Biol & Biochem, Ctr Med Biol, Ctr Peptide & Prot Engn, Belfast BT9 7BL, Antrim, North Ireland
关键词
MTT; NAC; neurotoxicity; Parkinson's disease; alpha-synuclein;
D O I
10.1046/j.1471-4159.2001.00408.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The non-beta-amyloid (A beta) component of Alzheimer's disease amyloid (NAC) and its precursor alpha -synuclein have been linked to amyloidogenesis in several neurodegenerative diseases. NAC and alpha -synuclein both form beta -sheet structures upon ageing, aggregate to form fibrils, and are neurotoxic. We recently established that a peptide comprising residues 3-18 of NAC retains these properties. To pinpoint the exact region responsible we have carried out assays of toxicity and physicochemical properties on smaller fragments of NAG. Toxicity was measured by the ability of fresh and aged peptides to inhibit the reduction of the redox dye 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) by rat pheochromocytoma PC12 cells and human neuroblastoma SHSY-5Y cells. On immediate dissolution, or after ageing, the fragments NAC(8-18) and NAC(8-16) are toxic, whereas NAC(12-18), NAC(9-16) and NAC(8-15) are not, Circular dichroism indicates that none of the peptides displays beta -sheet structure; rather all remain random coil throughout 24 h. However, in acetonitrile, an organic solvent known to induce beta sheet, fragments NAC(8-18) and NAC(8-16) both form beta -sheet structure. Only NAC(8-18) aggregates, as indicated by concentration of peptide remaining in solution after 3 days, and forms fibrils, as determined by electron microscopy, These findings indicate that residues 8-16 of NAG, equivalent to residues 68-76 in alpha -synuclein, comprise the region crucial for toxicity.
引用
收藏
页码:384 / 395
页数:12
相关论文
共 42 条
  • [1] α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation
    Arai, Y
    Yamazaki, M
    Mori, O
    Muramatsu, H
    Asano, G
    Katayama, Y
    [J]. BRAIN RESEARCH, 2001, 888 (02) : 287 - 296
  • [2] α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores
    Bayer, TA
    Jäkälä, P
    Hartmann, T
    Havas, L
    McLean, C
    Culvenor, JG
    Li, QX
    Masters, CL
    Falkai, P
    Beyreuther, K
    [J]. NEUROSCIENCE LETTERS, 1999, 266 (03) : 213 - 216
  • [3] Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs
    Biere, AL
    Wood, SJ
    Wypych, J
    Steavenson, S
    Jiang, YJ
    Anafi, D
    Jacobsen, FW
    Jarosinski, MA
    Wu, GM
    Louis, JC
    Martin, F
    Narhi, LO
    Citron, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34574 - 34579
  • [4] Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils
    Bodles, AM
    Guthrie, DJS
    Harriott, P
    Campbell, P
    Irvine, GB
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08): : 2186 - 2194
  • [5] Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
    Borghi, R
    Marchese, R
    Negro, A
    Marinelli, L
    Forloni, G
    Zaccheo, D
    Abbruzzese, G
    Tabaton, M
    [J]. NEUROSCIENCE LETTERS, 2000, 287 (01) : 65 - 67
  • [6] Conformations of synthetic beta peptides in solid state and in aqueous solution: Relation to toxicity in PC12 cells
    Buchet, R
    Tavitian, E
    Ristig, D
    Swoboda, R
    Stauss, U
    Gremlich, HU
    deLaFourniere, L
    Staufenbiel, M
    Frey, P
    Lowe, DA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1315 (01): : 40 - 46
  • [7] Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein
    Chauhan, A
    Chauhan, VPS
    Rubenstein, R
    Wegiel, J
    Wisniewski, HM
    [J]. NEUROCHEMICAL RESEARCH, 1997, 22 (02) : 227 - 232
  • [8] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [9] Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited -: NAC and α-synuclein are not associated with Aβ amyloid
    Culvenor, JG
    McLean, CA
    Cutt, S
    Campbell, BCV
    Maher, F
    Jäkälä, P
    Hartmann, T
    Beyreuther, K
    Masters, CL
    Li, QX
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) : 1173 - 1181
  • [10] Review:: Formation and properties of amyloid-like fibrils derived from α-synuclein and related proteins
    El-Agnaf, OMA
    Irvine, GB
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) : 300 - 309